47
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Im mune response with biodegradable nanospheres and alum : studies in rabbits using staphylococcal enterotoxin B-toxoid

Pages 215-225 | Published online: 29 Sep 2008

References

  • AGUADC:t M T., 1993, Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems. Vaccine, 11, 596–597.
  • BERDAL, R P., OLSVIK, 0., and OMLAND, T., 1981, A sandwich ELISA method for detec-tion of Staphylococcus aureus enterotoxins. A cta Pathologica-et- Microbiologica Scandinavica Section B, 89, 411–415.
  • CHANG, A. C„ and GUPTA, R K, 1996, Stabilization of tetanus toxoid in poly(DL-lactic-coglycolic acid) microspheres for the controlled release of antigen. Journal of Pharmaceutical Sciences, 85, 129–132.
  • CHANG, R S., KENDRICK, B. S., and CARPENTER, J. F., 1996, Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. Journal of Pharmaceutical Sciences, 85, 1325–1330.
  • ELDRIDGE, J. H., STAAS, J. K, CHEN D., MARX, P. A, TICE, T. R., and GILLEY, R. M., 1993, New advances in vaccine delivery systems. Seminars in Hematology, 30, 16–24.
  • ELDRIDGE, J. H., STAAS, J. K, MEULBROEK, J. A., TICE, T. R., and GILLEY, R. M., 1991, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphyloccoccal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infection and Immunity, 59, 2978–2986.
  • GUPTA, R K, and STIER, G. R. 1995, Adjuvants for human vaccines — current status, problems and future prospects. Vaccine, 13, 1263–1276.
  • IKOMI, F., HANNA, G. K, and SCHMID SCHONBEIN G. W., 1995, Mechanisms of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography. Radiology, 196, 107–113.
  • KREUTER, J., 1995, Nanoparticles as adjuvants for vaccines. Pharmaceutical Biotechnology, 6, 463–472.
  • KREUTER, J., 1996, Nanoparticles and microparticles for drug and vaccine delivery. Journal of Anatomy, 189, 503–505.
  • KREUTER, J., and SPEISER, P., 1976, In vitro studies of poly (methylmethcrylate) adjuvants. Journal of Pharmaceutical Sciences, 65, 1624–1627.
  • LABHASETWAR, V., BONADIQ J., GOLDSTEIN S. A, and LEVY, R. J., 1999, Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. Colloids and Surfaces B: Biointerfaces, 16, 281–290.
  • LIN, Y. S., LARGM T., NEwcom0, J. R., and ROGERS, T. J. 1988, Production andcharacterisation of monoclonal antibodies specific for staphylococcal enterotoxin B. Journal of Medical Microbiology, 27, 263–270.
  • Lusscw, A. R., AGuAng M T., DEL GIUDIC'E, G., and LAMBERT, P. H., 1990, Towards vaccine optimisation. Immunology Letters, 25, 255–263.
  • MANNING; M. C, PATEL, K, and BcRcHARur, R. T., 1989, Stability of protein pharmaceuticals. Pharmaceutical Research, 6, 903–918.
  • MARX, P. A, COMPANS, R. W., GETTIE, A, STAAS, J. K, GILLEY, R. M., MULLIGAN, M. J., YAMSCIIIKOV, G. V., CHEN D., and ELDRIDGE, J. H., 1993, Protection against vaginal SIV transmission with microencapsulated vaccine. Science, 260, 1323–1327.
  • MORIN, C, BARRATT, G., FESSI, H., DEVISSAGUET, J. P., and PUISIEUX, F., 1993, Biodegradable nanocapsules containing a lipophilic immunomodulator: drug retention and tolerance towards macrophages in vitro. Journal of Drug Targetting,l, 157–164.
  • MCRIN, C, BARRATT, G., FESSI, H., DEVISSAGUET, J. P., and PUISIEUX, F., 1994, Improved intracellular delivery of a muramyl dipeptide analog by means of nanocapsules. International Journal of Immunopharmacology, 16, 451–456.
  • O'HAGAN D. T., JEFFERY, H., ROBERTS, M. J., McGEE, J. P., and DAVIS, S. S., 1991, Controlled release microparticles for vaccine development. Vaccine, 9, 768–771.
  • O'HAGAN D. T., PALE'; K J., and DAVIS, S. S., 1989, Poly(buty1-2-cyanoacrylate) particles as adjuvants for oral immunization. Vaccine, 7, 213–216.
  • POWELL, M F., 1996, Drug delivery issues in vaccine development. Pharm Res, 13, 1777–1785.
  • RAGHUVANSHI, R. S., GANGA, S., MISRA, A, MEHTA, S., SINGH, 0., and PANDA, A. K, 1996, Stabilization of tetanus toxoid against dicholoromethane. Proceedings of the International Symposium, in Controlled Release of Bioactive Materials, 23, 859–860.
  • SCHWENDEMAN S. P., CaTANTINQ H. R., GuPrA, R K, Topaq M., CHANQ A. C, ALct\isq M. J., SIBER, G. R., and [ANGER, R., 1996, Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine. Developments in Biological Standardization, 87, 293–306.
  • SINGH, M, Li, X. M, MCGEE, J. R, ZAMB, T., KCFF, W., WANG; C Y., and OHAGAN D. T., 1997, Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. Vaccine, 15, 475–481

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.